-+ 0.00%
-+ 0.00%
-+ 0.00%

Corbus CEO Cohen base salary rises to $673,625 under amended employment agreement

PUBT·04/16/2026 20:20:39
Listen to the news
Corbus CEO Cohen base salary rises to $673,625 under amended employment agreement
  • Corbus Pharmaceuticals entered amended and restated employment agreements effective April 15, 2026 for Chief Executive Officer Yuval Cohen and Chief Financial Officer Sean Moran.
  • Cohen base salary set at $673,625 with annual bonus target up to 60% of base salary.
  • Moran base salary set at $501,273 with annual bonus target up to 40% of base salary.
  • Severance terms provide 12 months of base salary for Cohen, rising to 24 months during change in control period; Moran severance set at 12 months, rising to 18 months during change in control period.
  • Change in control provisions include accelerated vesting of outstanding equity awards; bonus payout set at 2x target for Cohen, target for Moran.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-159062), on April 16, 2026, and is solely responsible for the information contained therein.